Actively Recruiting

Age: 18Years +
All Genders
NCT05432739

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study

Led by Royal Marsden NHS Foundation Trust · Updated on 2023-06-15

500

Participants Needed

9

Research Sites

508 weeks

Total Duration

On this page

Sponsors

R

Royal Marsden NHS Foundation Trust

Lead Sponsor

R

Royal Brompton & Harefield NHS Foundation Trust

Collaborating Sponsor

AI-Summary

What this Trial Is About

NIMBLE is a prospective study for blood biomarker study of lung nodules alongside analysing data which has been collected routinely as part of patient care. The primary aim of NIMBLE is to assess whether artificial intelligence and machine learning based radiomics approaches can be used to distinguish between benign disease and malignancy in a new lung nodule after a previously treated cancer, and where malignant to differentiate between metastatic recurrence or a new primary lung cancer.

CONDITIONS

Official Title

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients under active investigation or surveillance for incidental lung nodules
  • Age over 18 years
Not Eligible

You will not qualify if you...

  • Active or previous diagnosis of malignancy within 5 years before the baseline scan
  • Unable to give informed consent
  • Active infection including tuberculosis or fungal infection
  • Clinician-suspected or confirmed active or recent COVID-19 infection within 4 weeks before CT scan or blood sampling

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Barking Havering and Redbridge University Hospitals NHS Trust

Goodmayes, Essex, United Kingdom, IG3 8YB

Actively Recruiting

2

Calderdale and Huddersfield NHS Foundation Trust

Huddersfield, United Kingdom, HD3 3EA

Actively Recruiting

3

Princess Alexandra Hospital

London, United Kingdom, CM20 1QX

Actively Recruiting

4

Whittington Health NHS Trust

London, United Kingdom, N19 5NF

Actively Recruiting

5

University College London Hospitals NHS Foundation Trust

London, United Kingdom, NW1 2BU

Actively Recruiting

6

Guy's and St Thomas' NHS Foundation Trust

London, United Kingdom, SE1 9RT

Actively Recruiting

7

Royal Marsden Hospital

London, United Kingdom, SW3 6JJ

Actively Recruiting

8

Northumbria NHS Foundation Trust

Newcastle upon Tyne, United Kingdom, NE27 0QJ

Actively Recruiting

9

Nottinghamshire Healthcare NHS Foundation Trust

Nottingham, United Kingdom, NG3 6AA

Actively Recruiting

Loading map...

Research Team

S

Sejal Jain

CONTACT

L

Laura Boddy

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study | DecenTrialz